Day 1 agenda

Wednesday, November 22

9.00-10.30

Conference opening

Plenary session – Main hall, screening to halls 1 and 2

Welcome speeches by keynote speakers and partners of the conference

Chair:
  • Jindřich Vobořil (National Drug Coordinator of the Czech Republic (aka “Czech drug czar”)
Speakers:
  • Michel Kazatchkine (member of the Global Commission on Drug Policy, and United Nations Secretary-General’s Special Envoy for AIDS in Eastern Europe and Central Asia)
  • Steph Sherer (Americans for Safe Access, and International Medical Cannabis Patients Consortium)
  • Ben Bronfman (Discorides Global Holdings)
  • Svatopluk Němeček (Czech Minister of Health 2014-2016, and Director of the Faculty Hospital in Ostrava)
  • Miroslava Němcová (Member of the Chamber of Commons, Czech Parliament)
  • Lumír Ondřej Hanuš (Hebrew University in Jerusalem, and The Lambert Center for the Study of Medicinal Cannabis and Hemp, Thomas Jefferson University, Philadelphia, USA)
  • Mark Ware (McGill University, and chair of the International Association for Cannabinoids Medicines)
  • Ethan Russo (ICCI, Phytecs, Inc, formerly GW Pharmaceuticals)

10.30-11.00             Coffee break

11.00-12.30

Medical cannabis regulation in Europe

Parallel session – main hall

Medical cannabis regulation systems in the EU: rules, implementation, outputs

Chair:
  • Ingo Ilja Michels (former Head of Unit of the Ministry of Health, Germany)
  • Brendan Hughes (EMCDDA)
Speakers:
  • Representatives of the National Medical Cannabis Agencies of the EU Member States

Cannabis, cannabinoids and cancer

Parallel session – hall 1

Where are we going? Status of the research, best practices in the use, case examples of successful current treatment procedures

Chair:
  • Jan Žaloudík (oncologist, director of Masaryk Memorial Cancer Institute)
Speakers:
  • Allan Frankel (Greenbridge Medical Services) + other participants based on abstracts selection

Educate your doctor

Parallel session – hall 2

No one will do it for you. How the patients should approach the information they gather from various sources, and how shall they use them when communicating with their practicians and specialists.

Chair:
  • Richard Rokyta (President of the Czech Medical Academy)
Speaker:
  • Steph Sherer (Americans for Safe Access, International Medical Cannabis Patients Consortium)

12.30-13.30             Lunch

13.30 – 15.00

Entourage effect: whole plant works better than individual components

Plenary session – main hall, screening to halls 1 and 2

Cannabis is a plant full of interrelated molecules. Although particular cannabinoids have proven results in curing particular medical conditions, using whole plant has an entourage effect: the cannabinoid complex works better when using a plant as a whole. Does one research paradigm fit for entourage effect, too?

Chair:
  • Lumír Ondřej Hanus (Hebrew University in Jerusalem, ICCI)
Speakers:
  • Ethan Russo (ICCI, Phytecs, Inc, formerly GW Pharmaceuticals)
  • Pal Pacher (National Institute on Alcohol Abuse and Alcoholism, NIH)
  • Tomáš Zábranský (ResAd, ICCI) + other participants based on abstracts selection

15.00 – 15.30          Coffee break

15.30 – 17.00

Controversies and needs in clinical studies

Parallel session, main hall

Cannabis and cannabinoids have been subject to intense research for a long time. Although scientists and doctors see the potential, general awareness and position of cannabis has been a source of controversial reactions to regular results of the research and corresponding clinical studies. What do researchers need to continue in their perspective research?

Chair:
  • Ethan Russo (ICCI, Phytecs, Inc, formerly GW Pharmaceuticals)
Speakers:
  • Allan Frankel (Greenbridge Medical Services)
  • Tomáš Zábranský (ResAd, ICCI)
  • + other discussants based on abstracts selection

Studies of medical cannabis policies

Parallel session, hall 1

Achievements, failures, pitfalls. There are various approaches which states could adopt towards cannabis as a medicine. Although medical cannabis is legal in most of the EU countries, its availability to patients is completely different matter. How can different states approach their cannabis policy, and what are the possible outcomes in the upcoming years?

Chair:
  • Alex Stevens (University of Kent, President of the ISSDP)
Speakers:
  • Allan Frankel (Greenbridge Medical Services)
  • Tomáš Zábranský (ResAd, ICCI)
  • + other discussants based on abstracts selection

Martina Kafková: A day in the life of medical cannabis patient

Parallel session – hall 2

Martina Kafková, most “famous” Czech cannabis patient, is being denied the only working medicine. Or at least the way she gets her medicine is extremely complicated and sometimes on the verge of law.

  • Martina need around 3 grams of cannabis per day, just to survive. Current system is effectively blocking her access to it.
  • The price in pharmacies would cost her 30.000 CZK per month, while the disabled pension is only 10.000 CZK. So like most of the patients, she must rely on the black market and friends.
  • Smoking several times a day is a necessity for Martina. Even during the night, she has to wake up and smoke cannabis. Otherwise she would die.
  • Special presentation

17.00 – 18.00          Coffee break

18.00-21.00

Festive gala reception

24th floor restaurant